Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. (Q54445461)
Jump to navigation
Jump to search
scientific article published in August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. |
scientific article published in August 2013 |
Statements
Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. (English)
1 reference
Minoru Oshima
1 reference
Keiichi Okano
1 reference
Shinobu Muraki
1 reference
Reiji Haba
1 reference
Takashi Maeba
1 reference
Yasuyuki Suzuki
1 reference
Shinichi Yachida
1 reference
1 August 2013
1 reference
258
1 reference
336-346
1 reference
2
1 reference
Identifiers
1 reference